Consensus Ipsen

Equities

Market Closed - Euronext Paris Other stock markets 09:08:02 26/04/2024 pm IST			5-day change	1st Jan Change
113 ^EUR	+0.62%		+4.24%	+4.73%

24/04	IPSEN : Better-than-expected Q1; guidance unchanged
24/04	Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024

db7374e.RhGciTLSc2FZQ2buHT_igTueKA6BNs4HaPmOC51HaV4.Mn6ovHqlElQyFie9U0jW0V79XEKwb4hSC7a2aqg_Wy8HeNbgdJEyIA4vFQ~fc07eec3dbfbf19962033e6c44d1b000

IPSEN : Better-than-expected Q1; guidance unchanged	24/04
IPSEN : Ipsen’s underlying fundamentals remain promising	13/03
Deutsche Bank Reduces Ipsen PT, Keeps Hold Rating	16/02	MT
IPSEN : Deutsche Bank cuts its target	16/02	CF
IPSEN : UBS reiterates its buy recommendation	14/02	CF
IPSEN : In line Q4 sales; lower-than-expected 2024 guidance	08/02
IPSEN : Deutsche Bank lowers its target price	15/12	CF
IPSEN : Ipsen outlined some promising mid-term takeaways at the CMD	08/12
IPSEN : UBS remains Buy after CMD	08/12	CF
IPSEN : RBC maintains 'in-line performance' rating	29/11	CF
IPSEN : Jefferies downgrades recommendation to 'hold	20/11	CF
IPSEN : Modest Q3 sales growth; guidance unchanged	26/23/26
Ipsen: upbeat with broker upgrade	12/23/12	CF
UBS Upgrades Ipsen to Buy from Neutral, Boosts PT	12/23/12	MT
IPSEN : UBS raises its recommendation	12/23/12	CF
IPSEN : RBC welcomes Cabometyx data	21/23/21	CF
IPSEN : AlphaValue upgrades its recommendation to 'buy	08/23/08	CF
IPSEN : Deutsche Bank raises its price target	08/23/08	CF
IPSEN : A compelling small Pharma	07/23/07
IPSEN : Healthy Q2 sales + a guidance upgrade	27/23/27
IPSEN : Healthy Q1 sales; full-year guidance maintained	27/23/27
IPSEN : Promising end to 2022	17/23/17
IPSEN : Oddo raises its target price	13/23/13	CF
IPSEN : Promising end to 2022	09/23/09
IPSEN : UBS reiterates its recommendation on the stock	24/23/24	CF